This project was support by the National Heart, Lung, and Blood Institute at the National Institutes of Health through SBIR Phase I and Phase II Contract HHSN268201000047C, and by Blood Systems Research Institute Contract 10734.
DONOR INFECTIOUS DISEASE TESTING
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
Article first published online: 4 JUL 2014
© 2014 The Authors. Transfusion published by Wiley Periodicals, Inc. on behalf of AABB.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Volume 54, Issue 9, pages 2237–2244, September 2014
How to Cite
Levin, A. E., Williamson, P. C., Erwin, J. L., Cyrus, S., Bloch, E. M., Shaz, B. H., Kessler, D., Telford, S. R., Krause, P. J., Wormser, G. P., Ni, X., Wang, H., Krueger, N. X., Caglioti, S. and Busch, M. P. (2014), Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion, 54: 2237–2244. doi: 10.1111/trf.12763
- Issue published online: 11 SEP 2014
- Article first published online: 4 JUL 2014
- Manuscript Revised: 19 MAY 2014
- Manuscript Accepted: 19 MAY 2014
- Manuscript Received: 12 MAR 2014
- National Heart, Lung, and Blood Institute at the National Institutes of Health. Grant Number: HHSN268201000047C
- Blood Systems Research Institute. Grant Number: 10734
Appendix S1. Supplemental methods.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.